Loading...
XNASPGNY
Market cap1.55bUSD
Jan 08, Last price  
18.25USD
1D
4.41%
1Q
10.94%
IPO
6.04%
Name

Progyny Inc

Chart & Performance

D1W1MN
XNAS:PGNY chart
P/E
25.05
P/S
1.43
EPS
0.73
Div Yield, %
0.00%
Shrs. gr., 5y
4.30%
Rev. gr., 5y
59.52%
Revenues
1.09b
+38.34%
48,584,000105,400,000229,683,000344,858,000500,621,000786,913,0001,088,598,000
Net income
62m
+104.35%
-12,452,000661,000-8,569,00046,459,00065,769,00030,358,00062,037,000
CFO
189m
+134.86%
-9,474,0002,272,000-1,534,00036,203,00026,037,00080,395,000188,814,000
Earnings
Feb 25, 2025

Profile

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
URL
https://www.progyny.com/
IPO date
Oct 25, 2019
Employees
393
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
1,088,598
38.34%
786,913
57.19%
Cost of revenue
1,026,414
763,572
Unusual Expense (Income)
NOPBT
62,184
23,341
NOPBT Margin
5.71%
2.97%
Operating Taxes
8,654
(5,917)
Tax Rate
13.92%
NOPAT
53,530
29,258
Net income
62,037
104.35%
30,358
-53.84%
Dividends
Dividend yield
Proceeds from repurchase of equity
(11,072)
(9,016)
BB yield
0.30%
0.29%
Debt
Debt current
2,149
1,231
Long-term debt
36,631
12,964
Deferred revenue
Other long-term liabilities
(3,016)
Net debt
(332,307)
(175,105)
Cash flow
Cash from operating activities
188,814
80,395
CAPEX
(3,644)
(3,241)
Cash from investing activities
(200,525)
(43,866)
Cash from financing activities
(11,072)
(7,864)
FCF
41,718
(17,907)
Balance
Cash
371,087
189,300
Long term investments
Excess cash
316,657
149,954
Stockholders' equity
92,799
28,444
Invested Capital
480,020
353,221
ROIC
12.85%
9.50%
ROCE
10.86%
6.07%
EV
Common stock shares outstanding
100,672
99,957
Price
37.18
19.36%
31.15
-38.13%
Market cap
3,743,000
20.21%
3,113,666
-38.38%
EV
3,410,693
2,938,561
EBITDA
64,465
24,942
EV/EBITDA
52.91
117.82
Interest
814
Interest/NOPBT
3.49%